Literature DB >> 14652800

Elevation of B-type natriuretic peptide levels in acute respiratory distress syndrome.

Micha Maeder1, Peter Ammann, Hans Rickli, Markus Diethelm.   

Abstract

BACKGROUND: B-type natriuretic peptide (BNP) has been proven to be a biochemical marker of severity of congestive heart failure. We are aware of only few papers reporting the association of BNP elevation and pulmonary hypertension (primary, thromboembolic, or as a consequence of chronic obstructive pulmonary disease). Less is known about BNP in patients with acute respiratory distress syndrome (ARDS). CASE DESCRIPTION AND
RESULTS: We present the case of a previously healthy 27-year-old man with parapneumonic ARDS and an extraordinarily increased BNP level. The ventricular systolic ejection fraction assessed echocardiographically was normal with no evidence of left ventricular diastolic dysfunction. However, a peak BNP level of >1300 pg/mL (normal <100 pg/mL) was recorded. Repeated BNP values were obtained on nine separate days over a period of 3 weeks of mechanical ventilation. With the respiratory improvement following the inhalation of nitric oxide BNP levels decreased to 113 pg/mL. The possible pathophysiological mechanisms of BNP release are discussed.
CONCLUSION: There is evidence for BNP elevation in the absence left ventricular dysfunction. This case is an example of impressively high BNP levels associated with ARDS, probably attributable to right ventricular overload due to increased pulmonary vascular resistance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14652800     DOI: 2003/37/smw-10367

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  7 in total

1.  The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill.

Authors:  Guangxi Li; Craig E Daniels; Marija Kojicic; Tami Krpata; Greg A Wilson; Jeffrey L Winters; S Breanndan Moore; Ognjen Gajic
Journal:  Transfusion       Date:  2008-10-14       Impact factor: 3.157

2.  The efficacy of cardiac findings in assessing the outcome in preterms with bronchopulmonary dysplasia.

Authors:  Abdullah Barış Akcan; Fırat Kardelen; Seyhan Erişir Oygucu; Abdullah Kocabaş; Deniz Ozel; Halide Akbaş; Nihal Oygür
Journal:  Indian J Pediatr       Date:  2013-03-17       Impact factor: 1.967

3.  Serum levels of N-terminal proB-type natriuretic peptide in mechanically ventilated critically ill patients--relation to tidal volume size and development of acute respiratory distress syndrome.

Authors:  Rogier M Determann; Annick A N M Royakkers; Jacqueline Schaefers; Anita M de Boer; Jan M Binnekade; Jan P van Straalen; Marcus J Schultz
Journal:  BMC Pulm Med       Date:  2013-07-09       Impact factor: 3.317

4.  The prognostic value of N-terminal proB-type natriuretic peptide in patients with acute respiratory distress syndrome.

Authors:  Chih-Cheng Lai; Mei-I Sung; Chung-Han Ho; Hsiao-Hua Liu; Chin-Ming Chen; Shyh-Ren Chiang; Chien-Ming Chao; Wei-Lun Liu; Shu-Chen Hsing; Kuo-Chen Cheng
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

5.  Potential role for furosemide in the treatment of acute respiratory distress syndrome (ARDS) and an unusual presentation of pulmonary embolism in a complex patient.

Authors:  Lior Zornitzki; Gil Bornstein
Journal:  BMJ Case Rep       Date:  2020-08-24

Review 6.  Serum and Urinary N-Terminal Pro-brain Natriuretic Peptides as Biomarkers for Bronchopulmonary Dysplasia of Preterm Neonates.

Authors:  Zoi Iliodromiti; Evangelos Christou; Nikolaos Vrachnis; Rozeta Sokou; Dionysios Vrachnis; Georgia Mihopoulou; Theodora Boutsikou; Nicoletta Iacovidou
Journal:  Front Pediatr       Date:  2020-10-28       Impact factor: 3.418

7.  Therapeutic hypothermia after cardiac arrest increases the plasma level of B-type natriuretic peptide.

Authors:  Yusuke Kashiwagi; Kimiaki Komukai; Haruka Kimura; Toraaki Okuyama; Tomoki Maehara; Keisuke Fukushima; Takahito Kamba; Yoshitsugu Oki; Keisuke Shirasaki; Takeyuki Kubota; Satoru Miyanaga; Tomohisa Nagoshi; Michihiro Yoshimura
Journal:  Sci Rep       Date:  2020-09-23       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.